Biocon Launches First US Manufacturing Facility in New Jersey

Biocon, a leading Bengaluru-based biopharmaceutical company, has opened its first manufacturing plant in the United States, located in Cranbury, New Jersey. This milestone strengthens Biocon’s global presence in pharma jobs in Hyderabad and beyond, marking a significant step in its expansion strategy.

Biocon’s New US Facility

On September 11, 2025, Biocon announced the inauguration of its new oral solid dosage (OSD) manufacturing facility, operated by its wholly-owned subsidiary, Biocon Generics (BGI). The plant, acquired from Eywa Pharma Inc. in 2023, represents a strategic investment to diversify Biocon’s manufacturing base.

The company has invested over $30 million to establish the facility, which boasts an annual production capacity of 2 billion tablets. Several products have already been commercialized from the site, with more in the pipeline.

Strengthening Global Supply Chains

The New Jersey facility enhances Biocon’s supply chain resilience and accelerates its global footprint. Approved by the USFDA, the plant underscores Biocon’s commitment to meeting stringent regulatory standards while delivering high-quality pharmaceutical products.

This investment supports Biocon’s goal of deeper engagement with healthcare providers and communities worldwide. It also complements the company’s robust operations in pharma jobs in Karnataka.

A New Chapter in Global Expansion

Kiran Mazumdar-Shaw, Chairperson of Biocon Group, described the facility as “a new chapter in our journey of global expansion.” She emphasized its role in fostering innovation and building a healthier, more equitable future.

The Cranbury plant reflects Biocon’s long-term commitment to advancing healthcare through strategic manufacturing capabilities. It positions the company to meet growing global demand for its products.

Why This Matters

The opening of Biocon’s first US manufacturing facility is a significant milestone for the Indian pharmaceutical industry. It enhances Biocon’s ability to serve international markets while creating opportunities for collaboration with global healthcare innovators.

For professionals seeking pharma jobs abroad, Biocon’s expansion signals exciting career prospects in a leading biopharmaceutical firm.

Learn More About Biocon

Stay updated on Biocon’s global initiatives and career opportunities. Visit biocon.com for more details on their innovative work in pharmaceuticals and biotechnology.